For instance, YAP stimulates AXL and EGFR transcription, and accordingly reinforces cellular resistance to EGFR inhibitor and docetaxcel in non-small cell lung cancer and esophageal cancer, respectively [27, 28]. Here, EGFR is linked to non-small cell lung carcinoma.